Ireland· IE-PA-PA0822/238/001
Atgam 50 mg/ml concentrate for solution for infusion
A antilymphocyte immunoglobulin (horse) product containing anti-t lymphocyte immunoglobulin for human use, horse, registered in Ireland by Pfizer Healthcare Ireland Unlimited Company. The same ATC class is registered in 9 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Antilymphocyte immunoglobulin (horse) is registered in 9 of 19 countries.
Countries holding a registration under ATC L04AA03 (antilymphocyte immunoglobulin (horse)), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 5 of them publish a price we can compare per daily dose
Antilymphocyte immunoglobulin (horse) · ATC L04AA03
9 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Anti-T Lymphocyte Immunoglobulin for Human Use, Horse
- Manufacturer
- Pfizer Healthcare Ireland Unlimited Company
- Country
- Ireland (IE)
- ATC code
- L04AA03
- ATC class
- Antilymphocyte immunoglobulin (horse)
- Defined daily dose
- 1.05 g, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0822/238/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L04AA03
Antilymphocyte immunoglobulin (horse), as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e209986a-4d47-4ea9-a729-663a5299cf09 GET /v1/drugs/e209986a-4d47-4ea9-a729-663a5299cf09?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Concentrate for solution for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"L04AA03"
],
"strength": null,
"pa_number": "PA0822/238/001",
"substances": [
"Anti-T Lymphocyte Immunoglobulin for Human Use, Horse"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "04/03/2022",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about antilymphocyte immunoglobulin (horse).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.